Foundation Medicine Coverage Initiated by Cowen

genomeweb
360dx

Foundation Medicine Coverage Initiated by Cowen

Feb 15, 2018

NEW YORK (GenomeWeb) – Cowen today initiated coverage of Foundation Medicine with an Outperform rating for its stock and a target price of $90 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Hologic M. Genitalium Assay Gets FDA De Novo Clearance
Biocartis Raises €55.5M in Equity Placement
Long-Read Genome Assemblies Have Many Errors in Protein-Coding Regions, Study Finds
Microbial Genomics Firm uBiome Lays Off 55 Employees
SpeeDx Signs Distribution Deals in Finland, Italy
Infectious Disease Firm Day Zero Diagnostics Raises $8.6M in Series A Round

The Scan

No Flu for These Birds

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

To Track Cholera

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Better Odds?

Vox explores a proposal to institute a lottery system to award grant funds.

This Week in Genome Biology

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.

Main menu